Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
What is the purpose of this trial?
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate may fight cancer by blocking the use of estrogen by tumor cells.
PURPOSE: This phase II trial is studying how well tamoxifen citrate works in patients with metastatic or recurrent breast cancer.
- 18 Years - N/A
- Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
- September 2010
- Last Updated:
- December 6, 2012
- Study HIC#:
Clinicaltrials.gov ID: NCT01124695